Intensity Modulated Radiotherapy in Recurrent T1-2 Nasopharyngeal Carcinoma

NCT02113423 · clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
168
Enrollment
OTHER_GOV
Sponsor class

Conditions

Interventions

Sponsor

Fujian Cancer Hospital